World Diabetes Day is celebrated every year on November 14. Why is diabetes so visible to the world? The incidence of diabetes is on the rise in almost every country in the world today. The disease is a leading cause of blindness, kidney failure, amputations, heart disease and strokes. The latest data from the International Diabetes Federation (IDF) shows that about 425 million adults worldwide suffered from diabetes in 2017, an average of 1 in 11 people. Diabetes is one of the most important causes of death, killing as many people as HIV/AIDS each year. Most diabetic patients are currently taking traditional medications to control their disease, or are injecting insulin externally to stabilize their blood glucose, but either way, they can only temporarily control their blood glucose without stopping the onset of complications. Metabolic (diabetic) surgery for diabetes is not an anecdote anymore, it is a real and effective way. Why is weight loss metabolic (diabetic) surgery so effective in treating diabetes? This is because weight loss surgery not only reduces body weight, but also reduces insulin resistance caused by fat accumulation, reduces glucose metabolic load, and effectively improves glucose metabolism. For example, gastric bypass surgery, known as the “gold standard procedure” for diabetes, is a surgical procedure that reduces the volume of the stomach, shuts down most of the stomach’s function, and changes the structure of the intestine, thus further reducing digestion and controlling absorption. Because the gastrointestinal tract reconstruction changes the secretion of hormones in the intestine-islet axis, thus improving glucose metabolism. After decades of clinical validation, a large amount of data has confirmed that 80% of obese type 2 diabetes patients can be free from drug dependence and maintain normal blood glucose within 3 to 5 years through metabolic (diabetes) surgery; surgery can significantly reduce the risk of long-term complications in diabetic patients and greatly reduce cardiovascular events, such as the risk of microvascular and macrovascular can be reduced by about 1/2 to 1/3; 60% to 80% of The risk of 13 types of malignant tumors, such as lung cancer, breast cancer, colon cancer, etc., can be reduced by metabolic surgery; from the perspective of health economics, the cost of one-time metabolic surgery is much lower than that of long-term medical treatment, and the cost of surgical treatment is comparable to that of medical treatment within 5-10 years. From the health economics point of view, the cost of one-time metabolic surgery is much lower than that of long-term internal medicine treatment, and the cost of surgery and internal medicine treatment is comparable in 5-10 years, which is more cost-effective. Secondly, it can play a good preventive role for high-risk type of people (overweight and obese patients) and reduce the risk of diabetes by 78%. Therefore, any diabetic patient who meets the criteria for surgery can try weight loss metabolic (diabetes) surgery, and it will benefit you for life.